Home » Newsletters » BioWorld MedTech

BioWorld MedTech

March 23, 2016

View Archived Issues

Sequenom seeks cert in scrum with Ariosa over the '540 patent

New self-confirming assay addresses the 'seroconversion' window

Boston Sci launches Axios system to treat pancreatitis complications

Fi nancings

Daily M&A

Product briefs

Oncology Extra

MIT polymer raises $25 million in early stage deal for Gecko Biomedical

PARIS – Would you pay $25 million to come in on the ground floor of Super Glue? Read More

GERD is the word: Treatment of esophageal disorders in spotlight

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...